Waters Corporation has introduced BioResolve™ RP mAb Polyphenyl 450 angstrom 2.7 micron solid core Columns intended for the reversed-phase analysis of intact or sub-unit-digested monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs) using LC-UV and LC-MS.

Award recognizes real and innovative solutions to problems faced by Idiopathic Pulmonary Fibrosis sufferers.

First GE Healthcare FlexFactory™ for cell therapy installation in the world expected to provide CBMG with scalable, fully-equipped cell therapy manufacturing capabilities, training and services.

If you currently use a CO₂ incubator or are planning to in the near future we would appreciate your feedback. We estimate the survey will take about 5-10 minutes to complete.

Aseptika Limited (Activ8rlives) has again been recognised as a leading HealthTech Innovator by their listing in the 2017 Global Digital Health 100 List.

Extended labeling claim adds detection of three additional gene mutations to provide the most comprehensive mutation panel for GILOTRIF®

New pan-cancer cell-free total nucleic acid (cfTNA) assay and FFPE-based tumor mutation load analysis assay, coupled with new Ion AmpliSeq HD technology, extend industry-leading Oncomine menu and enable panel design customization.

Thermo Fisher Scientific today announced the Ion GeneStudio S5 Series, a new line of bench top next-generation sequencing (NGS) instruments that enable low cost per sample for small and large projects across multiple research applications.

Utilizing a newly created artificial intelligence ("AI") based assay development system, the company succeeded in developing molecular diagnostics ("MDx") assays in only four (4) days.

Porvair Sciences are teaming up with Suzhou Tianlong Bio Technology Co Ltd (China), together with Swansea University and Xi'an Jiaotong University in a collaborative project entitled, "Automating & Stratification of Epigenetics in Healthcare" that is part of the Innovate UK / Jiangsu Industrial Challenge Programme.